71 reports

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products...

  • Pancreatic Cancer
  • Clinical Trial
  • United States
  • Smoking Prevalence
  • Drug Approval

Major players in the pancreatic cancer drugs market are Eli Lilly and Company, F. Hoffman LA Rouch, Clovis Oncology, Pfizer, Novartis AG, Amgen, Celegene Corporation, AB Science, GlaxoSmithKline and Abbvie Inc. The global pancreatic cancer drugs market is expected to grow from $3.45 billion in 2021 to $3.71 billion in 2022 at a compound...

  • Pancreatic Cancer
  • World
  • United States
  • Japan
  • Middle East
  • APAC
  • Drug Approval
  • Mortality Rate

Pancreatic Cancer Therapeutics and Diagnostics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pancreatic Cancer Therapeutics and Diagnostics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pancreatic...

  • Diagnostics
  • Pancreatic Cancer
  • World

Pancreatic Cancer (Oncology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Drugs In Development, 2021, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in...

  • Pancreatic Cancer
  • World

Pancreatic Cancer - Epidemiology Forecast to 2029 Summary Pancreatic cancer (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C25) is the seventh leading cause of cancer deaths worldwide.Pancreatic cancer occurs when cells in the pancreas...

  • Pancreatic Cancer
  • World
  • Cancer Incidence
  • Cancer Mortality

Major players in the pancreatic cancer drugs market are Eli Lilly and Company, F. Hoffman LA Rouch, Clovis Oncology, Pfizer, and Novartis AG. The global pancreatic cancer drugs market is expected to grow from $0.6 billion in 2020 to $0.61 billion in 2021 at a compound annual growth rate (CAGR) of 1.7%. The growth is mainly due to the...

  • Pancreatic Cancer
  • United States
  • World
  • Mortality Rate
  • Drug Approval

Pancreatic Cancer Therapeutics and Diagnostics Market Report Overview Pancreatic Cancer Therapeutics and Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pancreatic Cancer Therapeutics and Diagnostics market types and applications....

  • Diagnostics
  • Pancreatic Cancer
  • World
  • Health Provider Density

Abstract: - Global Pancreatic Cancer Drugs Market to Reach $3.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Pancreatic Cancer Drugs estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at aCAGR of 6.8% over the period 2020-2027....

  • Pancreatic Cancer
  • World
  • China
  • United States

Abstract: - Global Alpha Emitters Market to Reach $5.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Alpha Emitters estimated at US$672.3 Million in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 34.1% over the analysis period 2020-2027. Melanoma,...

  • Ovarian Cancer
  • Pancreatic Cancer
  • World
  • China
  • United States

Fibroblast Growth Factor 2 - Pipeline Review, H2 2020 Summary Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) pipeline Target constitutes close to 10 molecules. Out of which approximately 7 molecules are developed by companies and remaining...

  • Pharmaceutical
  • Therapy
  • Pancreatic Cancer
  • Protein Therapy
  • World
  • Vessel Fleet

Pancreatic Cancer - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H2 2020, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant...

  • Pancreatic Cancer
  • World

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under...

  • Pancreatic Cancer
  • World

Pancreatic Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2020, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant...

  • Pancreatic Cancer
  • World

Major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc., Pfizer, Bristol-Myers Squibb, Merck & Co. Inc. and Tepnel Pharma Services. The global precision medicine market is expected to grow from $72.58 billion in 2021 to $83.16 billion in 2022...

  • Pharmaceutical
  • Therapy
  • Oncology
  • Pancreatic Cancer
  • Bioinformatics
  • Diagnostics
  • World
  • APAC
  • Cancer Mortality

Major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc., Pfizer, Bristol-Myers Squibb, Merck & Co. Inc., Tepnel Pharma Services, Abbott Laboratories, Takeda Pharmaceutical Company Ltd., and Eli Lilly and Company. The global precision medicine...

  • Pharmaceutical
  • Therapy
  • Oncology
  • Pancreatic Cancer
  • Bioinformatics
  • Diagnostics
  • World
  • APAC
  • United States
  • Cancer Mortality

Fibroblast Growth Factor 2 - Pipeline Review, H1 2020 Summary Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) – Basic fibroblast growth factor also known as bFGF or FGF2 is a member of the fibroblast growth factor family. This protein plays...

  • Therapy
  • Pancreatic Cancer
  • Protein Therapy
  • World
  • Vessel Fleet

Serine/Threonine Protein Kinase Pim 3 - Pipeline Review, H1 2020 Summary According to the recently published report ’SerineThreonine Protein Kinase Pim 2 - Pipeline Review, H1 2020’; Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) pipeline Target constitutes...

  • Pharmaceutical
  • Leukemia
  • Therapy
  • Pancreatic Cancer
  • World

Serine/Threonine Protein Kinase Pim 1 - Pipeline Review, H1 2020 Summary Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Proto-oncogene serine/threonine-protein kinase Pim-1 is an enzyme encoded by the PIM1 gene. It promotes cell cycle progression and tumorigenesis...

  • Leukemia
  • Oncology
  • Prostate Cancer
  • Pharmaceutical
  • Pancreatic Cancer
  • Heart Attack
  • Gene Therapy
  • World

Cell Division Cycle 7 Related Protein Kinase - Pipeline Review, H2 2019 Summary Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Cell division cycle 7-related protein kinase is an enzyme encoded by the CDC7 gene. It phosphorylate substrates that regulate the G1/S phase transition...

  • Oncology
  • Drug Development
  • Therapy
  • Pancreatic Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Exports

Cell Division Cycle 7 Related Protein Kinase - Pipeline Review, H1 2020 Summary Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) – Cell division protein kinase 7 is an enzyme that in humans is encoded by the CDK7 gene. CDK7 is the catalytic subunit of the CDK-activating kinase...

  • Pharmaceutical
  • Therapy
  • Drug Development
  • Oncology
  • Pancreatic Cancer
  • World
  • Medical Technology Density

C-X-C Chemokine Receptor Type 1 - Pipeline Review, H2 2019 Summary C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed...

  • Protein Therapy
  • Pancreatic Cancer
  • World
  • Cancer Mortality
  • Unmet Needs For Medical Care

C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) pipeline Target constitutes close to 17 molecules. Out of which approximately 15...

  • Therapy
  • Protein Therapy
  • Oncology
  • Monoclonal Antibody
  • Oncology
  • Pancreatic Cancer
  • World
  • Unmet Needs For Medical Care
  • Drug Approval

Community Oncology Services Market Global Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global community oncology services market. This report focuses on community oncology services market which is experiencing strong growth....

  • Clinic
  • Skin Cancer
  • Marketing Research
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Prostate Cancer
  • Renal Cancer
  • Pancreatic Cancer
  • World

Macrophage Stimulating Protein Receptor - Pipeline Review, H2 2019 Summary Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) pipeline Target constitutes close to 7 molecules. The latest report Macrophage Stimulating Protein...

  • Oncology
  • Pharmaceutical
  • Pancreatic Cancer
  • World
  • Drug Approval
  • Health Provider Density

Carcinoembryonic Antigen Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Carcinoembryonic Antigen Market Size, Outlook and Growth Opportunities to 2025: By Application (Colorectal cancer, Pancreatic cancer, Breast cancer, Lung cancer, Ovarian cancer, and Others), By End User (Hospitals, Diagnostic centers,...

  • Healthcare
  • Diagnostics
  • Specialty Hospital
  • Laboratory
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Research Center
  • Pancreatic Cancer
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical-stage biotechnology company.The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor-specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic...

  • Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Cervical Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Clinical Trial
  • United States
  • World
  • North America
  • Medical Devices Sales

Summary Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer.The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diagnosis and screening...

  • Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Clinical Trial
  • Colorectal Cancer
  • Arthritis
  • Esophageal Cancer
  • World
  • United States
  • United Kingdom
  • North America
  • Europe
  • Northern Europe
  • Mobile Coverage
  • Medical Devices Sales

Summary Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that offers laboratory medicine solutions.The company’s products include amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approval, development, discovery,...

  • Diagnostics
  • Cancer
  • Lung Cancer
  • Genome Sequencing
  • Neurological Disorder
  • Esophageal Cancer
  • Pancreatic Cancer
  • Dementia
  • United States
  • World
  • North America
  • Medical Devices Sales

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2019 Summary According to the recently published report ’Macrophage Stimulating Protein Receptor - Pipeline Review, H1 2019’; Macrophage Stimulating Protein...

  • Pharmaceutical
  • Oncology
  • Pancreatic Cancer
  • World
  • Drug Approval
  • Health Provider Density

U.S. Biliary Stents Market by Type (Metal Biliary stents, and Plastic Biliary stents), Application (Malignant Obstruction, Benign Biliary Strictures, Biliary Leaks, and Others), and End User (Hospitals, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2018 - 2025 The U.S. biliary stents...

  • Ambulatory Care
  • Pancreatic Cancer
  • United States
  • Cancer Mortality